Methods and compositions for treating allergic asthma using descarboethoxyloratadine
US5962464A · kind A · utility
5Cited by
12References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 1998 |
| Grant date | Oct 5, 1999 |
| Priority date | — |
| Expiry date | Jul 6, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods utilizing descarboethoxyloratadine ("DCL"), for the treatment of allergic disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines. Also included are methods for the treatment of allergic asthma using DCL and either a decongestant or a leukotriene inhibitor, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines. The invention also encompasses the administration of DCL in a nasal or oral spray.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.